Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Weight decreased? 1,661 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,661 reports of Weight decreased have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 4.5% of all adverse event reports for EMPAGLIFLOZIN.

1,661
Reports of Weight decreased with EMPAGLIFLOZIN
4.5%
of all EMPAGLIFLOZIN reports
25
Deaths
328
Hospitalizations

How Dangerous Is Weight decreased From EMPAGLIFLOZIN?

Of the 1,661 reports, 25 (1.5%) resulted in death, 328 (19.7%) required hospitalization, and 67 (4.0%) were considered life-threatening.

Is Weight decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 1,661 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201) Acute kidney injury (1,023)

What Other Drugs Cause Weight decreased?

ADALIMUMAB (9,387) INFLIXIMAB (5,612) METHOTREXATE (5,432) SACUBITRIL\VALSARTAN (5,030) RITUXIMAB (4,866) APREMILAST (4,692) PREDNISONE (4,351) LENALIDOMIDE (4,235) ETANERCEPT (3,609) SEMAGLUTIDE (3,518)

Which EMPAGLIFLOZIN Alternatives Have Lower Weight decreased Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Weight decreased Reports All Drugs Causing Weight decreased EMPAGLIFLOZIN Demographics